Clinical significance of determination of surrogate markers of angiogenesis in breast cancer
- 2 February 2001
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 37 (2) , 97-114
- https://doi.org/10.1016/s1040-8428(00)00105-0
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cellsCancer Letters, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionBreast Cancer Research and Treatment, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Is the relationship between angiogenesis and metastasis in breast cancer real?Surgical Oncology, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990